...
首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival.
【24h】

Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival.

机译:具有长期无病生存期的非小细胞肺癌患者放疗后肺功能发生变化。

获取原文
获取原文并翻译 | 示例

摘要

Purpose: To evaluate the changes in pulmonary function after high-dose radiotherapy (RT) for non-small-cell lung cancer in patients with a long-term disease-free survival. Methods and Materials: Pulmonary function was measured in 34 patients with inoperable non-small-cell lung cancer before RT and at 3 and 18 months of follow-up. Thirteen of these patients had a pulmonary function test (PFT) 36 months after RT. The pulmonary function parameters (forced expiratory volume in 1 s [FEV(1)], diffusion capacity [T(lcoc)], forced vital capacity, and alveolar volume) were expressed as a percentage of normal values. Changes were expressed as relative to the pre-RT value. We evaluated the impact of chronic obstructive pulmonary disease, radiation pneumonitis, mean lung dose, and PFT results before RT on the changes in pulmonary function. Results: At 3, 18, and 36 months, a significant decrease was observed for the T(lcoc) (9.5%, 14.6%, and 22.0%, respectively) and the alveolar volume (5.8%, 6.6%, and 15.8%, respectively). The decrease in FEV(1) was significant at 18 and 36 months (8.8% and 13.4%, respectively). No recovery of any of the parameters was observed. Chronic obstructive pulmonary disease was an important risk factor for larger PFT decreases. FEV(1) and T(lcoc) decreases were dependent on the mean lung dose. Conclusion: A significant decrease in pulmonary function was observed 3 months after RT. No recovery in pulmonary function was seen at 18 and 36 months after RT. The decrease in pulmonary function was dependent on the mean lung dose, and patients with chronic obstructive pulmonary disease had larger reductions in the PFTs.
机译:目的:评估长期无病生存的非小细胞肺癌大剂量放疗(RT)后肺功能的变化。方法和材料:在RT之前以及随访的3个月和18个月,对34例不能手术的非小细胞肺癌患者进行了肺功能检查。这些患者中有13位在RT后36个月接受了肺功能检查(PFT)。肺功能参数(1秒内的呼气量[FEV(1)],扩散能力[T(lcoc)],强迫肺活量和肺泡容量)以正常值的百分比表示。变化表示为相对于RT前值。我们评估了慢性阻塞性肺疾病,放射性肺炎,平均肺剂量和放疗前的PFT结果对肺功能变化的影响。结果:在3、18和36个月时,T(lcoc)和肺泡量分别显着下降(分别为9.5%,14.6%和22.0%),分别为5.8%,6.6%和15.8%,分别)。 FEV(1)的下降在18和36个月时显着(分别为8.8%和13.4%)。没有观察到任何参数的恢复。慢性阻塞性肺疾病是PFT下降较大的重要危险因素。 FEV(1)和T(lcoc)的降低取决于平均肺剂量。结论:放疗后3个月,肺功能明显下降。 RT后18个月和36个月未见肺功能恢复。肺功能的下降取决于平均肺剂量,患有慢性阻塞性肺疾病的患者的PFT降低幅度更大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号